Diffuse Large B-Cell Lymphoma: ESMO Clinical Practice Guidelines

Published in 2012 – Ann Oncol 2012; 23 (Suppl 7): vii78-vii82.

Authors: H. Tilly, U. Vitolo, J. Walewski, M. Gomes da Silva, O. Shpilberg, M. André, M. Pfreundschuh, M. Dreyling

ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up on diffuse large B-cell lymphoma (DLBCL) covers recommendations for young low-risk patients without bulky disease, young low-intermediate-risk patients or IPI low risk with bulky disease, young high and high-intermediate-risk patients, patients aged 60–80 years, patients aged >80 years, and CNS prophylaxis.

Download the PDF from Annals of Oncology